Mood disorders and complementary and alternative medicine: a literature review

References

• HermanPMPoindexterBLWittCMEisenbergDMAre complementary therapies and integrative care cost-effective? A systematic review of economic evaluationsBMJ Open20122e001046
   PubMed Web of Science ®Google Scholar
• World Health OrganizationWorld Mental Health Survey Consortium: prevalence, severity and unmet need for treatment of mental disorders in WHO world mental health surveysJAMA20042912581259015173149
   PubMed Web of Science ®Google Scholar
• BrometEAndradeLHHwangICross-national epidemiology of DSM-IV major depressive episodeBMC Med201199021791035
   PubMed Web of Science ®Google Scholar
• KesslerRCThe costs of depressionPsychiatr Clin North Am20123511422370487
   PubMed Web of Science ®Google Scholar
• Fandino-LosadaAForsellYLundbergIDemands, skill discretion, decision authority and social climate at work as determinants of major depression in a 3-year follow-up studyInt Arch Occup Environ Health742012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• NordentoftMPrevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groupsDan Med Bull20015430636918208680
   PubMed Web of Science ®Google Scholar
• FreemanEJColpeLJStrineTWPublic health surveillance for mental healthPrev Chronic Dis20107A1720040232
   PubMed Web of Science ®Google Scholar
• LauterbachERumpfHJAhrensBAssessing dimensional and categorical aspects of depression: validation of the AMDP Depression ScaleEur Arch Psychiatry Clin Neurosci2005255151915538595
   PubMed Web of Science ®Google Scholar
• BaumeisterHHutterNBengelJPsychological and pharmacological interventions for depression in patients with coronary artery diseaseCochrane Database Syst Rev20119CD00801221901717
   PubMed Web of Science ®Google Scholar
• National Health ServiceDepression in adults with a chronic physical health problemNICE clinical guideline 912010 Available from: http://www.nice.org.uk/guidance/CG91Accessed March 20, 2013
   Google Scholar
• MaesMKuberaMObuchowiczwaEGoehlerLBrzeszczJDepression’s multiple comorbidities explained by neuroinflammatory and oxidative and nitrosative stress pathwaysNeuro Endocrinol Lett20113272421407167
   PubMed Web of Science ®Google Scholar
• Al-HarbiKSTreatment-resistant depression: therapeutic trends, challenges, and future directionsPatient Prefer Adherence2012636938822654508
   PubMed Web of Science ®Google Scholar
• Al-HarbiKSQureshiNANeuromodulation therapies and treatment-resistant depressionMed Devices (Auckl)20125536523152710
   PubMedGoogle Scholar
• American Psychiatric AssociationDiagnostic and Statistical Mental Disorders, Fourth Edition, Text RevisionWashington, DCAmerican Psychiatric Association1994
   Google Scholar
• World Health OrganizationInternational Classification of Diseases-10Geneva, SwitzerlandWorld Health Organization1990
   Google Scholar
• WalpoleSCMcMillanDHouseACottrellDMirGInterventions for treating depression in Muslim patients: a systematic reviewJ Affect Disord2013145112022854098
   PubMed Web of Science ®Google Scholar
• BartolomucciALeopardiRStress and depression: preclinical research and clinical implicationsPLoS One20094e426519180237
   PubMed Web of Science ®Google Scholar
• FavaMFarabaughAHSickingerAHPersonality disorders and depressionPsychol Med2002321049105712214786
   PubMed Web of Science ®Google Scholar
• ItoNHoriAYabeTInvolvement of neuropeptide y signaling in the antidepressant-like effect and hippocampal cell proliferation induced by kososan, a kampo medicine, in the stress-induced depression-like model miceBiol Pharm Bull2012351775178323037167
   PubMed Web of Science ®Google Scholar
• WolkowitzOMReusVIMellonSHOf sound mind and body: depression, disease, and accelerated agingDialogues Clin Neurosci201113253921485744
   PubMedGoogle Scholar
• DacherEThe development of an integrated medical model: toward a postmodern medicineMicozziMSFundamentals of Complementary and Alternative MedicineNew York, NYChurchill Livingstone2001
   Google Scholar
• SarrisJClinical depression: an evidence-based integrative complementary medicine treatment modelAltern Ther Health Med201117263722314631
   PubMed Web of Science ®Google Scholar
• PampallonaSBolliniPTibaldiGKupelnickBMunizzaCCombined pharmacotherapy and psychological treatment for depression: a systematic reviewArch Gen Psychiatry20046171471915237083
   PubMed Web of Science ®Google Scholar
• ThaseMEEvaluating antidepressant therapies: remission as the optimal outcomeJ Clin Psychiatry200364 Suppl 13182514552652
   PubMed Web of Science ®Google Scholar
• BaghaiTCMollerHJRupprechtRRecent progress in pharmacological and non-pharmacological treatment options of major depressionCurr Pharm Des20061250351516472142
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry2006163284016390886
   PubMed Web of Science ®Google Scholar
• BambauerKZAdamsASZhangFPhysician alerts to increase antidepressant adherence: fact or fiction?Arch Intern Med200616649850416534035
   PubMedGoogle Scholar
• FavaMPharmacological approaches to the treatment of residual symptomsJ Psychopharmacol200620 Suppl 3293416644769
   PubMed Web of Science ®Google Scholar
• PetersenTJEnhancing the efficacy of antidepressants with psychotherapyJ Psychopharmacol200620 Suppl 3192816644768
   PubMed Web of Science ®Google Scholar
• Department of Ayush, Ministry of Health and Family Welfare Available from: http://indianmedicine.nic.in/Accessed October 10, 2012
   Google Scholar
• PerronBEJarmanCNKilbourneAMAccess to conventional mental health and medical care among users of complementary and alternative medicine with bipolar disorderJ Nerv Ment Dis200919728729019363387
   PubMed Web of Science ®Google Scholar
• JarmanCNPerronBEKilbourneAMTehCFPerceived treatment effectiveness, medication compliance, and complementary and alternative medicine use among veterans with bipolar disorderJ Altern Complement Med20101625125520192909
   PubMed Web of Science ®Google Scholar
• NahasRSheikhOComplementary and alternative medicine for the treatment of major depressive disorderCan Fam Physician20115765966321673208
   PubMed Web of Science ®Google Scholar
• MuskinPRIntroduction: herbs and hermeneuticsComplementary and Alternative Medicine and PsychiatryArlington, VAAmerican Psychiatric Press Inc2005
   Google Scholar
• LaPatraJHealing: The Coming Revolution in Holistic MedicineNew York, NYMcGraw-Hill1978
   Google Scholar
• Al-BedahAPublic perspective: information and insights in complementary and alternative medicineOman Med J2012272022359720
   PubMedGoogle Scholar
• RavindranAVLamRWFilteauMJCanadian Network for Mood and Anxiety Treatments (CANMAT) Canadian Network for Mood and Anxiety Treatments (CANMAT)Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatmentsJ Affect Disord2009117 Suppl 1S54S6419666194
   PubMed Web of Science ®Google Scholar
• FreemanMPFavaMLakeJTrivediMHWisnerKLMischoulonDComplementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force reportJ Clin Psychiatry20107166968120573326
   PubMed Web of Science ®Google Scholar
• HoendersHJAppeloMTvan den BrinkEHHartogsBMAde JongJTVMThe Dutch Complementary and Alternative Medicine (CAM) protocol: to ensure safe and effective use of CAM within Dutch mental health careJ Complement Altern Med20111711971201
   PubMed Web of Science ®Google Scholar
• GuptaSChauhanDMehlaKSoodPNairAAn overview of nutraceuticals: current scenarioJ Basic Clin Pharm201015562
   PubMedGoogle Scholar
• BottiglieriTS-Adenosyl-L-methionine (SAMe) from the bench to the bedside- molecular basis of pleiotrophic moleculeAm J Clin Nutr2002761151S1157S12418493
   PubMed Web of Science ®Google Scholar
• BrownRPGerbargPLBottiglieriTS-Adenosylmethionine (SAMe) for depression: biochemical and clinical evidencePsychiatr Ann2002322944
   Web of Science ®Google Scholar
• CarpenterDJSt John’s wort and S-adenosyl methionine as “natural” alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit?Altern Med Rev201116173921438644
   PubMedGoogle Scholar
• PapakostasGICassielloCFIovienoNFolates and s-adenosylmethionine for major depressive disorderCan J Psychiatry20125740641322762295
   PubMed Web of Science ®Google Scholar
• FreemanMPMischoulonDTedeschiniEComplementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressantsJ Clin Psychiatry20107168268820573327
   PubMed Web of Science ®Google Scholar
• AlpertJEPapakostasGMischoulanDS-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineJ Clin Psychopharmacol20042466166415538131
   PubMed Web of Science ®Google Scholar
• PapakostasGIMischoulonDShyuIAlpertJEFavaMS-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trialAm J Psychiatry201016794294820595412
   PubMed Web of Science ®Google Scholar
• ErnstEComplementary medicineCurr Opin Rheumatol20031515115512598804
   PubMed Web of Science ®Google Scholar
• GrassettoMVarrattoAPrimary fibromyalgia is responsive to S-adenosyl-L-methionineCurr Ther Res199455797806
   Web of Science ®Google Scholar
• LieberCSS-adenosyl-L-methionine: its role in the treatment of liver diseasesAm J Clin Nutr200276S1183S1187
   PubMed Web of Science ®Google Scholar
• AleynikSILieberCSPolienylphosphatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring s-adenosylmethionineAlcohol Alcohol20033820821212711653
   PubMed Web of Science ®Google Scholar
• Di RoccoARogersJDBrownRWernerPBottiglieriTS-adenosyl-L-methionine improves depression in patients with Parkinson’s disease in an open label clinical trialMov Disord2000151225122911104210
   PubMed Web of Science ®Google Scholar
• ShippyRAMendezDJonesKCergnulIKarpiakSES-adenosyl-L-methionine (SAMe) for the treatment of depression in people living with HIV/AIDSBMC Psychiatry200443815538952
   PubMed Web of Science ®Google Scholar
• CeruttiRSichelMPPerinMPsychological distress during puerperium: a novel therapeutic approach using S-adenosylmethionineCurr Ther Res199353707716
   Web of Science ®Google Scholar
• SurteesRHylandKA method for the measurement of S-adenosylmethionine in small volume samples of cerebrospinal fluid or brain using high-performance liquid chromatography-electro chemistryAnn Biochem1989181333335
   Web of Science ®Google Scholar
• LevkovitzYAlpertJEBrintzCEMischoulonDPapakostasGIEffects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorderJ Affect Disord201231174117821911258
   PubMed Web of Science ®Google Scholar
• BrownRPGerbergPLMuskinPRMood disordersHow to Use Herbs, Nutrients and Yoga in Mental HealthNew York, NYWW Norton & Company2009
   Google Scholar
• El-AlfyATAbourashedEAMatsumotoRRNature against depressionCurr Med Chem2012192229224122414105
   PubMed Web of Science ®Google Scholar
• IovienoNDaltonEDFavaMMischoulonDSecond-tier natural antidepressants: review and critiqueJ Affect Disord201113034335720579741
   PubMed Web of Science ®Google Scholar
• LindeKRamirezGMulrowCDPaulsAWesdenhammerWMelchartDSt John’s Wort for depression – an overview and metaanalysis of randomized clinical trialsBMJ19963132532588704532
   PubMed Web of Science ®Google Scholar
• VorbachEUArnoldtKHHübnerWDEfficacy and tolerability of St John’s wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10Pharmacopsychiatry199730 Suppl 281859342765
   PubMed Web of Science ®Google Scholar
• SchraderEEquivalence of St John’s wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depressionInt Clin Psychopharmacol200015616810759336
   PubMed Web of Science ®Google Scholar
• SheltonRCKellerMBGelenbergAEffectiveness of St John’s wort in major depression: a randomized controlled trialJAMA20012851978198611308434
   PubMed Web of Science ®Google Scholar
• GelenbergAJSheltonRCCrits-ChristophPThe effectiveness of St John’s wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationJ Clin Psychiatry2004651114111915323598
   PubMed Web of Science ®Google Scholar
• [No authors listed]Hypericum Depression Trial Study GroupEffect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trialJAMA20022871807181411939866
   PubMed Web of Science ®Google Scholar
• BjerkenstedtLEdmanGVAlkenRGMannelMHypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatientsEur Arch Psychiatry Clin Neurosci2005255404715538592
   PubMed Web of Science ®Google Scholar
• MorenoRATengCTAlmeidaKMTavares JuniorHHypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sampleRev Bras Psiquiatr200628293216612487
   PubMed Web of Science ®Google Scholar
• FavaMAlpertJNierenbergAAA double-blind, randomized trial of St John’s wort, fluoxetine, and placebo in major depressive disorderJ Clin Psychopharmacol20052544144716160619
   PubMed Web of Science ®Google Scholar
• ChenJAPapakostasGIYounSJAssociation between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study GroupJ Clin Psychiatry2011721669167622053942
   PubMed Web of Science ®Google Scholar
• KasperSAnghelescuIGSzegediADienelAKieserMSuperior efficacy of St John’s wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]BMC Med200641416796730
   PubMed Web of Science ®Google Scholar
• GastparMSingerAZellerKEfficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertralinePharmacopsychiatry200538788615744631
   PubMed Web of Science ®Google Scholar
• SzegediAKohnenRDienelAKieserMAcute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetineBMJ200533050315708844
   PubMed Web of Science ®Google Scholar
• WheatleyDHypericum in seasonal affective disorder (SAD)Curr Med Res Opin199915333710216809
   PubMed Web of Science ®Google Scholar
• SingerASchmidtMHaukeWStadeKDuration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trialPhytomedicine20111873974221514125
   PubMed Web of Science ®Google Scholar
• RapaportMHNierenbergAAHowlandRDordingCSchettlerPJMischoulonDThe treatment of minor depression with St John’s Wort or citalopram: failure to show benefit over placeboJ Psychiatr Res20114593194121632064
   PubMed Web of Science ®Google Scholar
• GellerSEStudeeLBotanical and dietary supplements for mood and anxiety in menopausal womenMenopause2007143 Pt 154154917194961
   PubMed Web of Science ®Google Scholar
• BorrelliFIzzoAAHerb-drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observationsAAPS J20091171072719859815
   PubMed Web of Science ®Google Scholar
• KasperSGastparMMöllerHJBetter tolerability of St John’s wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depressionInt Clin Psychopharmacol20102520421320568656
   PubMed Web of Science ®Google Scholar
• KnüppelLLindeKAdverse effects of St John’s wort: a systematic reviewJ Clin Psychiatry2004651470147915554758
   PubMed Web of Science ®Google Scholar
• ThakorVLeachMJGillhamDEstermanAThe quality of information on websites selling St John’s wortComplement Ther Med20111915516021641521
   PubMed Web of Science ®Google Scholar
• ClausonKASantamarinaMLRutledgeJCClinically relevant safety issues associated with St John’s wort product labelsBMC Complement Altern Med200884218637192
   PubMed Web of Science ®Google Scholar
• McCreaCEPritchardMEConcurrent herb-prescription medication use and health care provider disclosure among university studentsComplement Ther Med201119323621296265
   PubMed Web of Science ®Google Scholar
• EdwardsDHeufelderAZimmermannATherapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms – results of an open-label studyPhytother Res2012261220122522228617
   PubMed Web of Science ®Google Scholar
• PanossianAWikmanGSarrisJRosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacyPhytomedicine20101748149320378318
   PubMed Web of Science ®Google Scholar
• DarbinyanVAslanyanGAmroyanEGabrielyanEMalmströmCPanossianAClinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depressionNord J Psychiatry20076134334817990195
   PubMed Web of Science ®Google Scholar
• ChanSWPanax ginseng, Rhodiola rosea and Schisandra chinensisInt J Food Sci Nutr201263 Suppl 1758122039930
   PubMed Web of Science ®Google Scholar
• KellyGSRhodiola rosea: a possible plant adaptogenAltern Med Rev2001629330211410073
   PubMedGoogle Scholar
• van DiermenDMarstonABravoJReistMCarruptPAHostettmannKMonoamine oxidase inhibition by Rhodiola rosea L. rootsJ Ethnopharmacol200912239740119168123
   PubMed Web of Science ®Google Scholar
• DwyerAVWhittenDLHawrelakJAHerbal medicines, other than St John’s wort, in the treatment of depression: a systematic reviewAltern Med Rev201116404921438645
   PubMedGoogle Scholar
• SarrisJPanossianASchweitzerIStoughCScholeyAHerbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidenceEur Neuropsychopharmacol20112184186021601431
   PubMed Web of Science ®Google Scholar
• LiLTWangSHGeHYChenJYueSWYuMThe beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depressionJ Altern Complement Med20081484184618721085
   PubMed Web of Science ®Google Scholar
• RaiVKattarPKhatoonSRawatAKSMehrotraSHeavy metal accumulation in some herbal drugsPharm Biol200139384387
   Web of Science ®Google Scholar
• HuggetDBKahnIAAllgoodJCBlockDSSchlenkDOrganochlorine pesticides and metals in select botanical dietary supplementsBull Environ Contam Toxicol20016615015511116308
   PubMed Web of Science ®Google Scholar
• ErnstECoonJTHeavy metals in traditional Chinese medicine: a systematic reviewClin Pharmacol Ther20017049750411753265
   PubMed Web of Science ®Google Scholar
• RaiVKakkarPSinghJMisraCKumarSMehrotraSToxic metals and organochlorine pesticides residue in single herbal drugs used in important Ayurvedic formulation- ‘Dashmoola’Environ Monit Assess200814327327717922233
   PubMed Web of Science ®Google Scholar
• GasserUKlierBKühnAVSteinhoffBCurrent findings on the heavy metal content in herbal drugsPharmeur Sci Notes20091375019275871
   PubMedGoogle Scholar
• SullivanJGreenfieldJCumberfordGGrantJStewartJExtraction efficiencies of heavy metals in hydroethanolic solvent from herbs of commerceJ AOAC Int20109349649820480895
   PubMed Web of Science ®Google Scholar
• RosecransRDohnalJCThe effect of complimentary and alternative medicine products on laboratory testingSemin Diagn Pathol200926384819292027
   PubMed Web of Science ®Google Scholar
• SadovskyRCollinsNTigheAPBruntonSASafeerRPatient use of dietary supplements: a clinician’s perspectiveCurr Med Res Opin2008241209121618348745
   PubMed Web of Science ®Google Scholar
• PosadzkiPWatsonLErnstEContamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviewsEur J Clin Pharmacol20136929530722843016
   PubMed Web of Science ®Google Scholar
• Ellsworth-BowersERCorwinEJNutrition and the psychoneuroimmunology of postpartum depressionNutr Res Rev20122518019222853878
   PubMed Web of Science ®Google Scholar
• BottiglieriTFolate, vitamin B12, and neuropsychiatric disordersNutr Rev1996543823909155210
   PubMed Web of Science ®Google Scholar
• CrellinRBottiglieriTReynoldsEHFolates and psychiatric disorders. Clinical potentialDrugs1993456236367686459
   PubMed Web of Science ®Google Scholar
• ProcterAEnhancement of recovery from psychiatric illness by methylfolateBr J Psychiatry19911592712721773245
   PubMed Web of Science ®Google Scholar
• BellIREdmanJSMorrowFDBrief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunctionJ Am Coll Nutr1992111591631578091
   PubMed Web of Science ®Google Scholar
• CoppenABaileyJEnhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trialJ Affect Disord20006012113010967371
   PubMed Web of Science ®Google Scholar
• ChristensenHAikenABatterhamPJNo clear potentiation of antidepressant medication effects by folic acid + vitamin B12 in a large community sampleJ Affect Disord2011130374520805005
   PubMed Web of Science ®Google Scholar
• WalkerJGMackinnonAJBatterhamPMental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trialBr J Psychiatry2010197455420592433
   PubMed Web of Science ®Google Scholar
• LangeHSuryapranataHDe LucaGFolate therapy and in-stent restenosis after coronary stentingN Engl J Med20043502673268115215483
   PubMed Web of Science ®Google Scholar
• HainesSTParkSKVitamin D supplementation: what’s known, what to do, and what’s neededPharmacotherapy20123235438222461123
   PubMed Web of Science ®Google Scholar
• DumvilleJCMilesJNPorthouseJCockayneSSexonLKingCCan vitamin D supplementation prevent winter-time blues? A randomized trial among older womenJ Nutr Health Aging20061015115316554952
   PubMed Web of Science ®Google Scholar
• JordeRSneveMFigenschauYSvartbergJWaterlooKEffects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trialJ Intern Med200826459960918793245
   PubMed Web of Science ®Google Scholar
• KjærgaardMWaterlooKWangCEEffect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trialBr J Psychiatry201220136036822790678
   PubMed Web of Science ®Google Scholar
• Bertone-JohnsonERPowersSISpanglerLVitamin D supplementation and depression in the women’s health initiative calcium and vitamin D trialAm J Epidemiol201217611322573431
   PubMed Web of Science ®Google Scholar
• TariqMMStreetenEASmithHAVitamin D: a potential role in reducing suicide risk?Int J Adolesc Med Health20112315716522191178
   PubMedGoogle Scholar
• HirashimaFParowAMStollALOmega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorderAm J Psychiatry20041611922192415465995
   PubMed Web of Science ®Google Scholar
• ParkerGGibsonNABrotchieHHerucGReesAMHadzi-PavlovicDOmega-3 fatty acids and mood disordersAm J Psychiatry200616396997816741195
   PubMed Web of Science ®Google Scholar
• Rocha AraujoDMVilarimMMNardiAEWhat is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression?Expert Rev Neurother2010101117112920586692
   PubMed Web of Science ®Google Scholar
• SubletteMEEllisSPGeantALMannJJMeta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depressionJ Clin Psychiatry2011721577158421939614
   PubMed Web of Science ®Google Scholar
• GertsikLPolandREBreseeCRapaportMHOmega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorderJ Clin Psychopharmacol201232616422198441
   PubMed Web of Science ®Google Scholar
• SubletteMEHibbelnJRGalfalvyHOquendoMAMannJJOmega-3 polyunsaturated essential fatty acid status as a predictor of future suicide riskAm J Psychiatry20061631100110216741213
   PubMed Web of Science ®Google Scholar
• McNamaraRKHahnCGJandacekRSelective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorderBiol Psychiatry200762172417188654
   PubMed Web of Science ®Google Scholar
• FreemanMPHibbelnJRWisnerKLOmega-3 fatty acids: evidence basis for treatment and future research in psychiatryJ Clin Psychiatry2006671954196717194275
   PubMed Web of Science ®Google Scholar
• SuKPHuangSYChiuCCShenWWOmega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trialEur Neuropsychopharmacol20031326727112888186
   PubMed Web of Science ®Google Scholar
• NemetsBStahlZBelmakerRHAddition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorderAm J Psychiatry200215947747911870016
   PubMed Web of Science ®Google Scholar
• TimonenMHorrobinDJokelainenJLaitinenJHervaARäsänenPFish consumption and depression: the Northern Finland 1966 birth cohort studyJ Affect Disord20048244745215555697
   PubMed Web of Science ®Google Scholar
• MurphyBLStollALHarrisPQOmega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trialJ Clin Psychopharmacol20123269970322926607
   PubMed Web of Science ®Google Scholar
• McNamaraRKEvaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendationsProstaglandins Leukot Essent Fatty Acids20098122323119515544
   PubMed Web of Science ®Google Scholar
• NoaghiulSHibbelnJRCross-national comparisons of seafood consumption and rates of bipolar disordersAm J Psychiatry20031602222222714638594
   PubMed Web of Science ®Google Scholar
• OsherYBersudskyYBelmakerRHOmega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label studyJ Clin Psychiatry20056672672915960565
   PubMed Web of Science ®Google Scholar
• FrangouSLewisMMcCronePEfficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled studyBr J Psychiatry2006188465016388069
   PubMed Web of Science ®Google Scholar
• KeckPEJrMintzJMcElroySLDouble-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderBiol Psychiatry2006601020102216814257
   PubMed Web of Science ®Google Scholar
• OsherYBelmakerRHOmega-3 fatty acids in depression: a review of three studiesCNS Neurosci Ther20091512813319499625
   PubMed Web of Science ®Google Scholar
• SarrisJMischoulonDSchweitzerIOmega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depressionJ Clin Psychiatry201273818621903025
   PubMed Web of Science ®Google Scholar
• HibbelnJRSeafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysisJ Affect Disord200269152912103448
   PubMed Web of Science ®Google Scholar
• SuKPHuangSYChiuTHOmega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trialJ Clin Psychiatry20086964465118370571
   PubMed Web of Science ®Google Scholar
• FreemanMPHibbelnJRWisnerKLBrumbachBHWatchmanMGelenbergAJRandomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depressionActa Psychiatr Scand2006113313516390366
   PubMed Web of Science ®Google Scholar
• DeligiannidisKMFreemanMPComplementary and alternative medicine for the treatment of depressive disorders in womenPsychiatr Clin North Am20103344146320385346
   PubMed Web of Science ®Google Scholar
• LustykMKBGerrishWGPremenstrual syndrome and premenstrual dysphoric disorder: issues of quality of life, stress and exercisePreedyVWatsonRRHandbook of Disease Burdens and Quality of Life MeasuresHeidelberg, GermanySpringer Science + Business Media LLC2010
   Google Scholar
• WozniakJBiedermanJMickEOmega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trialEur Neuropsychopharmacol20071744044717258897
   PubMed Web of Science ®Google Scholar
• LooMIntegrative Medicine for ChildrenSt Louis, MOSaunders Elsevier Inc2009
   Google Scholar
• BogarapuSBishopJRKruegerCDPavuluriMNComplementary medicines in pediatric bipolar disorderMinerva Pediatr20086010311418277369
   PubMedGoogle Scholar
• FrazierEAFristadMAArnoldLEFeasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disordersJ Altern Complement Med20121867868522747095
   PubMed Web of Science ®Google Scholar
• StollALSachsGSCohenBMLaferBChristensenJDRenshawPFCholine in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patientsBiol Psychiatry1996403823888874839
   PubMed Web of Science ®Google Scholar
• LyooIKDemopulosCMHirashimaFAhnKHRenshawPFOral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopyBipolar Disord2003530030612895208
   PubMed Web of Science ®Google Scholar
• BenjaminJAgamGLevineJBersudskyYKofmanOBelmakerRHInositol treatment in psychiatryPsychopharmacol Bull1995311671757675981
   PubMedGoogle Scholar
• SarrisJKavanaghDJByrneGAdjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepinesJ Psychiatr Res201044324119616220
   PubMed Web of Science ®Google Scholar
• ChengappaKNLevineJGershonSInositol as an add-on treatment for bipolar depressionBipolar Disord20002475511254020
   PubMed Web of Science ®Google Scholar
• NierenbergAAOstacherMJCalabreseJRTreatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidoneAm J Psychiatry200616321021616449473
   PubMed Web of Science ®Google Scholar
• BackEEHenningKJKallenbachLRBrixKAGunnRAMeliusJMRisk factors for developing eosinophilia myalgia syndrome (EMS) among L-tryptophan users in New YorkJ Rheumatol1993206666728496862
   PubMed Web of Science ®Google Scholar
• DasYTBagchiMBagchiDPreussHGSafety of 5-hydroxy-L-tryptophanToxicol Lett200415011112215068828
   PubMed Web of Science ®Google Scholar
• GijsmanHJvan GervenJMde KamMLPlacebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteersJ Clin Psychopharmacol20022218318911910264
   PubMed Web of Science ®Google Scholar
• SmagaIPomiernyBKrzyżanowskaWN-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in ratsProg Neuropsychopharmacol Biol Psychiatry20123928028722820675
   PubMed Web of Science ®Google Scholar
• SarrisJMischoulonDSchweitzerIAdjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trialsBipolar Disord20111345446522017215
   PubMed Web of Science ®Google Scholar
• DeanOGiorlandoFBerkMN-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionJ Psychiatry Neurosci201136788621118657
   PubMed Web of Science ®Google Scholar
• BlochMSchmidtPJDanaceauMAAdamsLFRubinowDRDehydroepiandrosterone treatment of midlife dysthymiaBiol Psychiatry1999451533154110376113
   PubMed Web of Science ®Google Scholar
• WolkowitzOMReusVIKeeblerADouble-blind treatment of major depression with dehydroepiandrosteroneAm J Psychiatry199915664664910200751
   PubMed Web of Science ®Google Scholar
• SchmidtPJDalyRCBlochMDehydroepiandrosterone monotherapy in midlife-onset major and minor depressionArch Gen Psychiatry20056215416215699292
   PubMed Web of Science ®Google Scholar
• RabkinJGMcElhineyMCRabkinRMcGrathPJFerrandoSJPlacebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDSAm J Psychiatry2006163596616390890
   PubMed Web of Science ®Google Scholar
• BlochMIsh-ShalomSGreenmanYKleinELatzerYDehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot studyPsychiatry Res201220054454922858403
   PubMed Web of Science ®Google Scholar
• SatowYEKumarPDBurkeAInciardiJFExploring the prevalence of Ayurveda use among Asian IndiansJ Altern Complement Med2008141249125319123878
   PubMed Web of Science ®Google Scholar
• PrathikantiSAyurvedic treatmentsLakeJSpiegelDComplementary and Alternative TreatmentsWashington, DCAmerican Psychiatric Publishing2007
   Google Scholar
• SharmaHChandolaHMSinghGBasishtGUtilization of Ayurveda in health care: an approach for prevention, health promotion, and treatment of disease. Part 2 – Ayurveda in primary health careJ Altern Complement Med2007131135115018166127
   PubMed Web of Science ®Google Scholar
• Ven MurthyMRRanjekarPKRamassamyCDeshpandeMScientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: AshwagandhaCent Nerv Syst Agents Med Chem20101023824620528765
   PubMedGoogle Scholar
• ShresthaBGTakagiYIshiiTWadhwaRKaulSCSelective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effectClin Cancer Res2007132298230617404115
   PubMed Web of Science ®Google Scholar
• MaityTAdhikariABhattacharyaKBiswasSDebnathPKMaharanaCSA study on evaluation of antidepressant effect of imipramine adjunct with Aswagandha and BramhiNepal Med Coll J20111325025323016473
   PubMedGoogle Scholar
• BhattacharyaSKBhattacharyaASairamKGhosalSAnxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental studyPhytomedicine2000746346911194174
   PubMed Web of Science ®Google Scholar
• [No authors listed]Monograph. Withania somniferaAltern Med Rev2004921121415253680
   PubMedGoogle Scholar
• RiouxJA complex, nonlinear dynamic systems perspective on Ayurveda and Ayurvedic researchJ Altern Complement Med20121870971822830972
   PubMed Web of Science ®Google Scholar
• VuddandaPRChakrabortySSinghSBerberine: a potential phytochemical with multispectrum therapeutic activitiesExpert Opin Investig Drugs20101912971307
   PubMed Web of Science ®Google Scholar
• PosmontierBTeitelbaumMAn Ayurvedic approach to postpartum depressionHolist Nurs Pract20092320121419574756
   PubMed Web of Science ®Google Scholar
• BawdenSRunning an NHS community homeopathy clinic – 10-year anniversary 2001–2011Homeopathy2012101515622226315
   PubMed Web of Science ®Google Scholar
• PilkingtonKKirkwoodGRampesHFisherPRichardsonJHomeopathy for depression: a systematic review of the research evidenceHomeopathy20059415316316060201
   PubMedGoogle Scholar
• MathieRTRobinsonTWOutcomes from homeopathic prescribing in medical practice: a prospective, research-targeted, pilot studyHomeopathy20069519920517015190
   PubMed Web of Science ®Google Scholar
• DavidsonJRCrawfordCIvesJAJonasWBHomeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studiesJ Clin Psychiatry20117279580521733480
   PubMed Web of Science ®Google Scholar
• SelhubEMind-body medicine for treating depression: using the mind to alter the body’s response to stressAlternative and Complementary Therapies20071349
   Google Scholar
• PilkingtonKKirkwoodGRampesHRichardsonJYoga for depression: the research evidenceJ Affect Disord200589132416185770
   PubMed Web of Science ®Google Scholar
• WoodCMood change and perceptions of vitality: a comparison of the effects of relaxation, visualization and yogaJ R Soc Med1993862542588505745
   PubMed Web of Science ®Google Scholar
• Shannahoff-KhalsaDSKundalini yoga meditation techniques for the treatment of obsessive-compulsive and OC spectrum disordersBrief Treat Crisis Interv20033369382
   Google Scholar
• LaveyRShermanTMueserKTOsborneDDCurrierMWolfeRThe effects of yoga on mood in psychiatric inpatientsPsychiatr Rehabil J20052839940215895926
   PubMed Web of Science ®Google Scholar
• WeintraubAYoga for Depression: A Compassionate Guide to Relieve Suffering Through YogaNew York, NYThree Rivers Press2004
   Google Scholar
• WooleryAMyersHSternliebBZeltzerLA yoga intervention for young adults with elevated symptoms of depressionAltern Ther Health Med200410606315055096
   PubMed Web of Science ®Google Scholar
• ShapiroDCookIADavydovDMOttavianiCLeuchterAFAbramsMYoga as a complementary treatment of depression: effects of traits and moods on treatment outcomeEvid Based Complement Alternat Med2007449350218227917
   PubMed Web of Science ®Google Scholar
• KhumarSSKaurPKSEffectiveness of Shavasana on depression in university studentsIndian J Clin Psychol1993208287
   Google Scholar
• TsangHWFungKMChanASLeeGChanFEffect of a qigong exercise programme on elderly with depressionInt J Geriatr Psychiatry20062189089716955451
   PubMed Web of Science ®Google Scholar
• JanakiramaiahNGangadharBNNagaVenkatesha MurthyPJHarishMGSubbakrishnaDKVedamurthacharAAntidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramineJ Affect Disord20005725525910708840
   PubMed Web of Science ®Google Scholar
• BrownRPGerbergPLSudarshan Kirya Yogic breathing in the treatment of stress, anxiety and depression: Part 1 Neurophysiologic modelJ Altern Complement Med20051118920115750381
   PubMed Web of Science ®Google Scholar
• BrownRPGerbergPLSudarshan Kirya Yogic breathing in the treatment of stress, anxiety and depression: Part I1 Clinical applications and guidelinesJ Altern Complement Med20051171171716131297
   PubMed Web of Science ®Google Scholar
• BennettSMWeintraubAKhalsaSSInitial evaluation of the LifeForce yoga program as a therapeutic intervention for depressionInt J Yoga Therap2008184957
   Google Scholar
• PanNLJiangMJPoonPWFHuangAMThe role of brain-derived neurotrophic factor in the antidepressant effects of Sudarshan Kriya YogaMaster’s thesis2006 Available from: http://ethesys.lib.ncku.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0808107-104238Accessed October 18, 2012
   Google Scholar
• ManochaRBlackDSarrisJStoughCA randomized, controlled trial of meditation for work stress, anxiety and depressed mood in full-time workersEvid Based Complement Alternat Med2011201196058321716708
   PubMed Web of Science ®Google Scholar
• KjellgrenABoodSAAxelssonKNorlanderTSaatciogluFWellness through a comprehensive Yogic breathing program – controlled pilot trialBMC Complement Altern Med200774318093307
   PubMedGoogle Scholar
• MehtaPSharmaMYoga as a complementary therapy for clinical depressionComplement Health Pract Rev201015156170
   Google Scholar
• EisendrathSChartierMMcLaneMAdapting mindfulness-based cognitive therapy for treatment-resistant depressionCogn Behav Pract20111836237022211062
   PubMed Web of Science ®Google Scholar
• PlodekJReiki: an ancient therapy in modern timesFreemanLMosby’s Complementary and Alternative Medicine: A Research-Based Approach3rd ed2009
   Google Scholar
• Available from: http://nccam.nih.gov/health/reiki/introduction.htmAccessed March 22, 2013
   Google Scholar
• BowdenDGoddardLGruzelierJA randomised controlled single-blind trial of the efficacy of Reiki at benefiting mood and well-beingEvid Based Complement Alternat Med2011201138186221584234
   PubMed Web of Science ®Google Scholar
• BlumenthalJABabyakMAMooreKAEffects of exercise training on older patients with major depressionArch Intern Med19991592349235610547175
   PubMed Web of Science ®Google Scholar
• CraftLLandersDThe effect of exercise on clinical depression and depression resulting from medical illness. A meta-analysisJ Sport Exerc Psychol199820339357
   Web of Science ®Google Scholar
• OttoMWChurchTSCraftLLGreerTLSmitsJATrivediMHExercise for mood and anxiety disordersJ Clin Psychiatry20076866967617503975
   PubMed Web of Science ®Google Scholar
• DunnALTrivediMHKampertJBClarkCGChamblissHOExercise treatment for depression: efficacy and dose responseAm J Prev Med2005281815626549
   PubMed Web of Science ®Google Scholar
• RichardsonCRAvripasSANealDLMarcusSMIncreasing lifestyle physical activity in patients with depression or other serious mental illnessJ Psychiatr Pract20051137938816304506
   PubMedGoogle Scholar
• KochSMorlinghausKFuchsTThe joy dance: specific effects of a single dance intervention on psychiatric patients with depressionArts Psychother200734340349
   Web of Science ®Google Scholar
• [No authors listed]. Available from: https://thequantumalliance.zendesk.com/entries/21055146-indigo-contraindications-for-biofeedbackAccessed April 8, 2013
   Google Scholar
• [No authors listed]. Available from: http://www.electrostimulateurs-manuels.fr/fichiers/publications/Contraindications-et-Precautions/contraindications.pdfAccessed April 8, 2013
   Google Scholar
• KaravidasMLehrerPVaschilloEPreliminary results of an open label study of heart rate variability biofeedback for the treatment of major depressionAppl Psychophysiol Biofeedback2007321193017333315
   PubMed Web of Science ®Google Scholar
• KimYHJThe effectiveness of acupuncture for treating depression: a reviewAlternative and Complementary Therapies2007
   Google Scholar
• YeungASAmeralVEChuziSEFavaMMischoulonDA pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorderJ Affect Disord201113028528920692042
   PubMed Web of Science ®Google Scholar
• MontiDABeitmanBDIntegrative PsychiatryOxford, UKOxford University Press2010
   Google Scholar
• MuskinPRComplementary and Alternative Medicine and PsychiatryArlington, VAAmerican Psychiatric Press Inc2000
   Google Scholar
• MischoulanDRosenbaumJFNatural Medications for Psychiatric Disorders2nd edPhiladelphia, PALippincott Williams & Wilkins2008
   Google Scholar
• VentegodtSMerrickJA review of side effects and adverse events of non-drug medicine (nonpharmaceutical complementary and alternative medicine): psychotherapy, mind-body medicine and clinical holistic medicineJ Complement Integr Med2009616
   Google Scholar
• MintzDLIntegrative approaches to depression and its treatmentPsychiatr Clin North Am201235xiiixvi22370502
   PubMed Web of Science ®Google Scholar
• MeyerBBergerTCasparFBeeversCGAnderssonGWeissMEffectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trialJ Med Internet Res200911e1519632969
   PubMed Web of Science ®Google Scholar
• van StratenACuijpersPSmitsNEffectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trialJ Med Internet Res20082510:e7
   Google Scholar
• WarmerdamLvan StratenATwiskJRiperHCuijpersPInternet-based treatment for adults with depressive symptoms: randomized controlled trialJ Med Internet Res200810e4419033149
   PubMed Web of Science ®Google Scholar
• ClarkeGEubanksDReidEOvercoming Depression on the Internet (ODIN) (2): a randomized trial of a self-help depression skills program with remindersJ Med Internet Res20057e1615998607
   PubMed Web of Science ®Google Scholar
• HoekWSchuurmansJKootHMCuijpersPPrevention of depression and anxiety in adolescents: a randomized controlled trial testing the efficacy and mechanisms of Internet-based self-help problem-solving therapyTrials2009109319821984
   PubMed Web of Science ®Google Scholar